NVZMY (Novonesis (Novozymes) B) FCF Margin % : 13.97% (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Novonesis (Novozymes) B's Free Cash Flow for the three months ended in Dec. 2024 was $293 Mil. Novonesis (Novozymes) B's Revenue for the three months ended in Dec. 2024 was $2,096 Mil. Therefore, Novonesis (Novozymes) B's FCF Margin % for the quarter that ended in Dec. 2024 was 13.97%.

As of today, Novonesis (Novozymes) B's current FCF Yield % is 1.09%.

The historical rank and industry rank for Novonesis (Novozymes) B's FCF Margin % or its related term are showing as below:

NVZMY' s FCF Margin % Range Over the Past 10 Years
Min: 6.36 Med: 16.4 Max: 24.37
Current: 13.97

During the past 13 years, the highest FCF Margin % of Novonesis (Novozymes) B was 24.37%. The lowest was 6.36%. And the median was 16.40%.

NVZMY's FCF Margin % is ranked better than
89.37% of 1533 companies
in the Chemicals industry
Industry Median: 1.39 vs NVZMY: 13.97

Novonesis (Novozymes) B FCF Margin % Historical Data

The historical data trend for Novonesis (Novozymes) B's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B FCF Margin % Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

24.37

18.87

6.36

11.71

17.22

Novonesis (Novozymes) B Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															13.78	24.93	17.95	-	13.97

Competitive Comparison of Novonesis (Novozymes) B's FCF Margin %

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's FCF Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Novonesis (Novozymes) B FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Novonesis (Novozymes) B's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	691.204	/	4014.136
	=	17.22 %

Novonesis (Novozymes) B's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	292.88	/	2096.126
	=	13.97 %

Novonesis (Novozymes) B FCF Margin % Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark NZM2:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.